The survey captured 204 responses, including 159 complete and 45 partial responses, across six countries. Question-level bases vary because partial responses were included before later questions. Percentages and response counts in the backend section are reproduced exactly from the source export.
Beyond Dispensing: What Is Holding Pharmacists Back?
A peer-level look at a profession asked to deliver more clinical care while the operating system still rewards speed, product flow, shortage management, and fragmented work. The role has evolved. The question is whether the infrastructure around it has.
Healthcare professionals: 204 responses
Complete responses: 159
Countries: 6
Survey ID: 8881721
-headline finding
– Quick Read — Key Findings
58.8%
68.1%
64.0%
93.2%
83.2%
50.6%
78.2%
88.2%
Read the full MDForLives insight report
Explore the complete story, every closed-question response, peer-voice themes, practice implications, and external context.
//Background and Methodology
Why we asked pharmacists about clinical transformation now
The pharmacist visible to patients is increasingly a clinician: administering vaccines, conducting screening and point-of-care testing, reviewing complex therapies, supporting chronic disease management, and resolving medication-safety risks. WHO/Europe has documented this expansion beyond traditional supply and dispensing as a way to improve patient care and reduce pressure on other health professionals.
The Agency for Healthcare Research and Quality describes pharmacists as central to medication safety across the care continuum, including recognizing prescription errors, providing medicine information, and leading safety programs. Yet the operating system around this clinical role still measures product movement more reliably than cognitive work.
This creates a structural mismatch. New clinical services are added to the same shift, often without removing production tasks, protecting consultation time, integrating records, or creating reliable payment for clinical judgment. Scope expands, but capacity is expected to appear on its own.
We asked practicing pharmacists across six countries to trace that mismatch through the full workflow: time allocation, remuneration, medication reviews, performance metrics, medicine shortages, education, collaboration, and technology. The curiosity is not whether pharmacists can provide more care. It is what must stop consuming the time, information, and economic space required to do it safely.
// Core Finding
The operating-model paradox: clinical responsibility is growing faster than the system that supports it
58.8% remain in production-dominant or production-weighted workflows, while 68.1% identify labor deficits or remuneration asymmetry as the main barrier to expanded clinical services. The profession is not waiting to become clinical. It is already carrying clinical responsibility inside a model that has not released the time or economics of production.
//The backstory behind the operating-model gap
The clinical role expanded by addition, not redesign
The transformation of pharmacy has often happened by layering new services onto an old production engine. Vaccination, testing, consultation, prescribing, safety review, and chronic-care support arrive as additional responsibilities, while dispensing queues, verification targets, inventory work, and shortage substitutions remain.
That is why the findings connect. A production-weighted shift limits clinical time. Limited clinical time makes service expansion dependent on staffing. Unpaid cognitive work weakens the business case for protected care. Throughput metrics compete with review quality. Missing records narrow judgment. Shortages redirect the same pharmacist time the system wants to use for patient care.
- Scope expands but the shift is not rebuilt around the expanded role.
- Clinical services are counted but often as quotas rather than outcomes.
- Clinical judgment grows while access to shared patient information remains uneven.
- Automation is offered as relief but pharmacists first ask for interoperability, time, and a viable care model.
//Workflow and remuneration
Why expanded scope does not automatically create clinical capacity
The largest barriers are staffing shortages and the absence of standardized payment for cognitive services. Permission to provide care is not enough when the shift remains built around production.
The medication review is squeezed by speed and missing information
Throughput-driven metrics and incomplete patient records together account for 64.0% of the factors most compromising clinical evaluation.
//Operational drag
The shortage tax is consuming the same clinical time the system wants to expand
83.2% spend more than two hours each week managing shortages, and almost one third spend six hours or more. The US Food and Drug Administration notes that drug shortages can arise from manufacturing and quality problems, production delays, and product discontinuations. Whatever the upstream cause, the downstream coordination burden lands inside pharmacy workflow.
//Technology and sustainability
Why pharmacists want shared records before more automation
50.6% prioritize bidirectional EHR interoperability. For long-term sustainability, payment reform and stronger oversight of intermediaries outrank a fully automated consultant model.
// Methodology and Context
How the findings were interpreted
Dermatology
7Endocrinology, Diabetes & Metabolism
7Oncology & Hematology
7Hospital Administration
6Ophthalmology
6Neurology
6Gastroenterology & Hepatology
6Pharmacy
6Primary Care & Family Medicine
6Diabetes, Weight & Metabolic Health
5Surgery & Procedural Care
5Dentistry & Oral Health
5Nurses, NPs & Physician Assistants
5Pediatrics
5
Cardiology
4Laboratory & Diagnostics
4Radiology & Imaging
3Optometry & Optical Care
3Skin & Aesthetic Care
2Insights for Patients & Caregivers
1Social Work & Patient Support
1Cancer Care
1
You have read the summary
Go deeper into the findings.
Be part of what comes next.
//People Also Ask
Frequently asked questions about the evolving role of pharmacists
Direct answers to the questions healthcare professionals are most likely to ask about these findings.
Is pharmacy practice really becoming more clinical?
The transition is visible but incomplete. 28.5% described their workflow as clinical-dominant, while 58.8% still spent most of the shift in production-dominant or production-weighted work.
What is stopping pharmacists from providing more clinical services?
Labor deficits were the leading barrier at 36.2%, followed by the lack of standardized payment for cognitive clinical services at 31.9%. Together, these barriers represented 68.1% of responses.
Why are comprehensive medication reviews difficult for pharmacists?
Throughput-driven performance metrics led at 32.3%, closely followed by incomplete patient records at 31.7%. Pharmacists therefore need both protected clinical time and access to complete clinical information.
How much time do pharmacists spend managing medicine shortages?
83.2% spent more than two hours each week managing shortages. 31.9% spent six hours or more sourcing alternatives, resolving inventory gaps, and coordinating therapeutic substitutions.
Which technology would help pharmacists most?
Bidirectional electronic health record access was the leading technology priority, selected by 50.6%. It ranked ahead of automated prescription verification, centralized fulfillment, and predictive supply-chain tools.
What reform is most important for pharmacy sustainability?
Stronger oversight of pharmacy middlemen ranked first at 32.7%, followed by separating pharmacist remuneration from physical product sales at 27.7%. The findings place economic reform at the center of clinical transformation.
Related Reports
Direct answers to the questions healthcare professionals are most likely to ask about these findings.
